Covid-19 roundup: Biden invests $1.7B to address Covid variants; EU puts faith in Pfizer with new vaccine deals

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

The Biden administration said Friday that it’ll pump $1.7 billion into various programs to address Covid-19 variants as the original strain of Covid-19 makes up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Biden invests $1.7B to address Covid variants; EU puts faith in Pfizer with new vaccine deals

Nicole DeFeudis

Editor

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Patient dies in Neurogene's Rett syndrome study

Are programs with compounded GLP-1s safe for your population?

Covid-19 roundup: Biden in­vests $1.7B to ad­dress Covid vari­ants; EU puts faith in Pfiz­er with new vac­cine deals

Editor

Senior Editor

Sign up to read this article for free.

Covid-19 roundup: Biden invests $1.7B to address Covid variants; EU puts faith in Pfizer with new vaccine deals